| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |